Could a CPAP machine make lung cancer radiation more accurate?
NCT ID NCT03422302
First seen Jun 25, 2026 · Last updated Aug 12, 2026 · Updated 3 times
Summary
This study tests whether a CPAP device can reduce tumor movement in lung cancer patients during stereotactic body radiation therapy (SBRT). About 30 participants will use CPAP or deep inspiration breath hold to see which better stabilizes tumors. The goal is to improve treatment precision and potentially reduce damage to healthy tissue.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Continuous positive airway pressure (CPAP) device
- What this could lead to
- If it works, this could make radiation therapy for lung cancer more precise by reducing tumor movement during treatment.
- What could go wrong
- This is a small early-phase pilot study with only 30 participants, so results may not apply broadly. The CPAP device may not reduce tumor motion better than standard breath-holding techniques.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New PET tracer could spot cancers that standard scans overlook
- Can a conversation aid empower lung cancer patients?
- Can couples coping together ease the burden of advanced cancer?
- Can a custom toolkit help indigenous smokers spot lung cancer earlier?
- Study tests if teaching doctors and patients boosts lung cancer screening
- Could a vaccine stop lung cancer in smokers? early trial launches